Introduction {#sec1}
============

The five-membered nitrogen heterocyclic compounds are gaining interest in organic synthesis because of their presence in a wide range of biologically active molecules. Pyrrolidines, five-membered saturated N-heterocycles, are found in a wide variety of natural products^[@ref1]^ and pharmaceuticals^[@ref2]^ ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}). For example, (+)-preussin (**1**) is an antifungal agent and it has growth-inhibitory and cytotoxic effects on human cancer cells^[@ref3]^ and ramipril (**2**) is an angiotensin-converting enzyme inhibitor used to treat high blood pressure and congestive heart failure.^[@ref4]^ Similarly, ABT-418 (**3**) is a cholinergic channel activator, which is also used for the treatment of both Alzheimer's disease and attention deficit hyperactivity disorder.^[@cit2a],[@cit2b]^

![Structures of pyrrolidine-containing bioactive compounds.](ao-2017-01785t_0007){#fig1}

In addition to their importance in medicinal chemistry, enantiomerically pure pyrrolidines are used as chiral auxiliaries for a number of different transformations.^[@ref5]^ Apart from these, pyrrolidine-based organocatalysts^[@ref6]^ and chiral ligands^[@ref7]^ are also employed in a wide range of organic transformations. Because of their enormous synthetic importance, several efforts have been made toward the synthesis of pyrrolidine such as intramolecular hydroamination of alkenes,^[@ref8]^ aza-Michael reaction,^[@ref9]^ nitro-Mannich/hydroamination cascade reaction,^[@ref10]^ ring transformation of 2-(haloalkyl)azetidines,^[@ref11]^ \[4 + 2\] cycloaddition reaction of nitroalkenes,^[@ref12]^ \[3 + 2\] cycloaddition reaction,^[@ref13]^ cyclization of nitrogen-containing acetals and ketals,^[@ref14]^ 2,3-dichloro-5,6-dicyano-1,4-benzoquinone-mediated amido cyclization reaction,^[@ref15]^ palladium-catalyzed carboamination reactions of γ-aminoalkenes with aryl and vinylhalides,^[@ref16]^ palladium-^[@ref17]^ and platinum-catalyzed^[@ref18]^ coupling reaction of N-sulfonated enynes, and gold-catalyzed intramolecular cyclization of N-tethered alkynes.^[@ref19]^ Lewis acids such as FeCl~3~^[@ref20]^ and InCl~3~^[@ref21]^ have also been used for cyclization of N-tethered alkyne-alkenol and C-tethered alkyne-allyl bromide, respectively. N-Tethered alkyne/alkenes are gaining importance in organic synthesis because of the formation of nitrogen heterocyclic compounds in a diastereoselective manner.^[@ref19]−[@ref23]^ Indium(III) salts have long been used in organic synthesis for different transformations. Indium trichloride has also been used as a Lewis acid catalyst^[@ref24]^ as well as a stoichiometric reagent^[@ref25]^ in various organic transformations to construct heterocycles, which involves both C--C and C--X (heteroatom) bond formations. The utility of indium trichloride as Lewis acids is encouraged by their unique π-acidity, alkynophilicity, relatively low toxicity, air, moisture compatibility, and recyclability. Recently, we have developed methodologies for the synthesis of oxygen and nitrogen heterocyclic compounds via intramolecular C--C and C--O bond formation from N-tethered alkyne-epoxides^[@ref22]^ and N-tethered alkynes consisting of alkanol and alkenol.^[@ref23]^ We now present a methodology for the synthesis of pyrrolidine using intramolecular C--C bond formation from N-tethered alkyne-alkenol mediated by InCl~3~ in moderate to good yields with good stereo- and regioselectivity.

To start with, (*Z*)-*N*-(4-hydroxybut-2-en-1-yl)-4-methyl-*N*-(3-phenylprop-2-yn-1-yl)benzenesulfonamide (**4d**) was treated with 1 equiv of BF~3~·OEt~2~ ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 1) in dichloromethane at room temperature (rt) for 12 h, but the reaction ended with no result; however, the starting material was recovered in 96% yield. On the other hand, treatment with 0.2 equiv of InCl~3~ ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 2) in dichloromethane at room temperature yielded compound **5d** as the E/Z mixture with a ratio of 18:82 in 10% overall yield. The structure of compound **5d** was determined by ^1^H and ^13^C NMR spectroscopy and comparison with the known compounds.^[@cit17d]^ Increasing the amount of InCl~3~ to 1.1 equiv resulted in only 18% yield with the E/Z ratio of 18:82. The same reaction at 40 °C resulted in 25% yield with the E/Z ratio of 20:80. The reaction with 0.2 equiv of InCl~3~ in 1,2-dichloeroethane (DCE) at 80 °C for 12 h gave **5d** with a E/Z ratio of 15:85 in 18% overall yield ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 5). Changing the solvent from DCE to CH~3~CN, CHCl~3~, and CCl~4~ ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entries 6--9) did not provide any good results. Addition of an external chloride source, trimethylsilyl chloride (TMSCl) ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 10), did not affect the yield but reduced the Z-selectivity of the reaction. On the other hand, treatment with 1.1 equiv of InCl~3~ at 80 °C in DCE for 12 h gave 75% of the desired product with the E/Z ratio of 16:84 ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 11). InBr~3~ ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 12) is less effective under these reaction conditions, and it produces chlorinated as well as brominated products **5d-Cl** and **5d-Br** with a ratio of 28:72. The E/Z selectivity is found to be 42:58 in both the cases (see [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b01785/suppl_file/ao7b01785_si_001.pdf)). This indicates that solvent DCE also participates in the reaction as per Cook's method.^[@ref21]^ The ratio of E and Z configurations was determined from the crude ^1^H NMR. In(OTf)~3~ ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entries 13--14) was found to be inactive under the similar reaction conditions. Other Lewis acids such as FeCl~3~ gave equal amounts of chlorinated **5d** and carbonyl product **6d** with 30--40% yields under different reaction conditions ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entries 15--16). CeCl~3~ was also found to be unsuitable for this reaction. Brønsted acids such as *p*-toluenesulfonic acid and triflic acid are found to be ineffective as well. Therefore, 1.1 equiv of InCl~3~ in DCE at 80 °C stands out to be the optimum condition for the reaction. The low yield at a lower temperature in CH~2~Cl~2~ and DCE might be due to the poor leaving property of the hydroxyl group. This is in contrast to Cook's procedure where 20 mol % InCl~3~ was used in CH~2~Cl~2~ to synthesize chlorinated cabocycles from allylic bromide in very good yields at room temperature.^[@ref21]^ This indicates that the allylic hydroxyl group is a poor leaving group and hence requires a higher temperature compared to that for allylic bromide. It may be noted that an extremely dry condition is essential for the formation of single chloroproducts without the formation of carbonyl side product **6d**.

###### Optimization of the Reaction

![](ao-2017-01785t_0003){#fx2}

                                                       % yield[a](#t1fn1){ref-type="table-fn"}                                                                     
  ---- --------------------------- --------- ---- ---- ----------------------------------------------------------------------- ----------------------------------- ---------------------------------------
  1    BF~3~·OEt~2~ (1.0)          DCM       rt   12   0                                                                       0                                    
  2    InCl~3~ (0.2)               DCM       rt   12   10                                                                      0                                   18:82
  3    InCl~3~ (1.1)               DCM       rt   12   18                                                                      0                                   18:82
  4    InCl~3~ (1.1)               DCM       40   12   25                                                                      0                                   20:80
  5    InCl~3~ (0.2)               DCE       80   12   18                                                                      0                                   15:85
  6    InCl~3~ (0.2)               CH~3~CN   85   24   trace                                                                   0                                    
  7    InCl~3~ (1.1)               CH~3~CN   85   24   trace                                                                   0                                    
  8    InCl~3~ (1.0)               CHC1~3~   65   24   0[b](#t1fn2){ref-type="table-fn"}                                       0[b](#t1fn2){ref-type="table-fn"}    
  9    InCl~3~ (1.0)               CC1~4~    80   12   20                                                                      0                                   14:86
  10   InCl~3~ (0.2)/TMSCl (1.0)   DCE       50   18   22                                                                      0                                   20:80
  11   InCl~3~ (1.1)               DCE       80   12   75                                                                      0                                   16:84
  12   InBr~3~ (1.1)               DCE       80   12   12[c](#t1fn3){ref-type="table-fn"}^,^[d](#t1fn4){ref-type="table-fn"}   0                                   42:58[e](#t1fn5){ref-type="table-fn"}
  13   In(OTf)~3~ (0.2)            DCE       80   5    0[b](#t1fn2){ref-type="table-fn"}                                       0[b](#t1fn2){ref-type="table-fn"}    
  14   In(OTf)~3~ (1.1)            DCE       80   5    0[b](#t1fn2){ref-type="table-fn"}                                       0[b](#t1fn2){ref-type="table-fn"}    
  15   FeCl~3~ (1.2)               DCE       rt   12   30                                                                      30                                  30:70
  16   FeCl~3~ (1.2)               DCE       60   4    40                                                                      40                                  18:82
  17   CeCl~3~·H~2~O (1.1)         CH~3~CN   80   24   0[b](#t1fn2){ref-type="table-fn"}                                       0[b](#t1fn2){ref-type="table-fn"}    
  18   TfOH (0.2)                  DCE       rt   12   0[d](#t1fn4){ref-type="table-fn"}                                       0[d](#t1fn4){ref-type="table-fn"}    
  19   *p*-TsOH (0.2)              DCE       80   24   0[d](#t1fn4){ref-type="table-fn"}                                       0[d](#t1fn4){ref-type="table-fn"}    

Yields are isolated yields.

Starting material recovered.

**5d-Cl**, **5d-Br**; ratio of **5d-Cl** to **5d-Br** = 28:72.

Decomposed products.

The E/Z ratio is 42:58 for both chloro and bromo products.

Results and Discussion {#sec2}
======================

With these optimized conditions in hand, we further examined the scope of the reaction and limitations with a variety of substrates ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}). The reaction works well for both alkyl and aryl groups present in the alkyne side chain delivering cyclized products in good yields. Substrates having electron-donating ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, entry 5) and moderately electron-withdrawing groups ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, entries 6--8) on the aromatic ring of the alkyne side chain gave desired products in good yields. Steric effects play a considerable role in the yield of the reaction, as reflected in substrates **4i** and **4j**, which produced low yields compared to those of other substrates. On the other hand, unsubstituted alkyne ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, entry 1) gave a lower yield as compared to that of the alkyl-substituted alkynes ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, entries 2--3). This might be due to the less stability of intermediate carbocation **D** (where R = H, [Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}) formed during the reaction. The reaction produced exclusively a pyrrolidine ring with exocyclic vinyl chloride at 3-position as well as a vinylic group at 4-position. It is observed from [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"} that the substrates having a substituted aromatic moiety attached to the alkyne side chain ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, entries 4--9) provide better Z-selectivity than that from those having alkyl groups ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, entries 2--3) in the alkyne side chain. This might be due to the steric hindrance of the bulky aromatic groups. There is an exception in the case of substrate **4j**. As the reaction becomes sluggish due to the presence of the bulky 3,5-dimethylphenyl group, there is a chance of chloride transfer from solvent DCE, which resulted in lower Z-selectivity. The E and Z configurations of the compounds were determined by the nuclear Overhauser effect (NOE) experiment of compounds *E*/*Z*-**5b** ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}) and also by comparison of E-configured **5b** with the literature data.^[@cit17d]^

![NOE of compounds *E*-**5b** and *Z***-5b**.](ao-2017-01785t_0001){#fig2}

![Plausible Mechanism of the Reaction](ao-2017-01785t_0002){#sch1}

###### Synthesis of 4-Vinylpyrrolidine

![](ao-2017-01785t_0004){#fx3}

Yield refers to isolated yields. All of the products were characterized by ^1^H, ^13^C, and mass spectrometry.

The ratio of E/Z isomers is determined by ^1^H NMR.

On the basis of observations, two mechanisms could be predicted for the reaction ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}). Stepwise carbocation formation and concerted reaction as proposed by Cook.^[@ref21]^ The Lewis acid activates the hydroxyl group of allylic alcohol to facilitate the nucleophilic attack by the alkyne group to generate chairlike transition states **A** and **B** of which **A** is disfavored because of the 1,3-diaxial interaction between the double bond and the lone pair over nitrogen of the tosyl amine group.^[@cit23b]^ More stable intermediate **B** after 5-endo-trig cyclization forms carbocation **D**. There are two possible ways of attacking carbocation **D** by a chloride ion. Pathway "b" is less likely due to the steric hindrance experienced by the incoming chloride ion with the vinyl group and gives minor E-configured product *E*-**5**. On the other hand, attacking carbocation **D** via path "a" is more likely as the incoming chloride ion experiences less such steric hindrance with the axial hydrogen. Therefore, the reaction via pathway "a" gives major Z-configured product *Z*-**5** ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}). The possibility of concerted mechanism as proposed by Cook cannot be ruled out as the reaction with InBr~3~ in ClCH~2~CH~2~Cl produced both chlorinated and brominated products **5d-Cl** and **5d-Br** with a ratio of 28:72 ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 12). As the chlorinated product is less compared with the brominated product, the rate of reaction via the stepwise reaction is faster than that via the concerted one. This also explains the requirement of stoichiometric amount of InCl~3~ in the present procedure.

Conclusions {#sec3}
===========

In conclusion, we have developed a methodology for the synthesis of vinyl-substituted pyrrolidine with stereo- and regioselectivity in moderate to good yields. We have also demonstrated that InCl~3~ can be used as a Lewis acid as well as a chlorinating agent for the synthesis of chlorinated pyrrolidines. The major advantage of the method is that it generates a pyrrolidine moiety having two functional groups, i.e., exocyclic vinyl chloride at 3-position as well as a vinylic group at 4-position of the pyrrolidine ring. The drawbacks of the procedure are the requirements of high temperature and stoichiometric amount of InCl~3~.

Experimental Section {#sec4}
====================

General Information {#sec4.1}
-------------------

All of the reagents were of reagent grade (AR grade) and were used as purchased without further purification. Silica gel (60--120 mesh size) was used for column chromatography. Reactions were monitored by thin-layer chromatography (TLC) on silica gel GF~254~ (0.25 mm). Melting points were recorded in an open capillary tube and are uncorrected. Fourier transform-infrared spectra were recorded as neat liquid or KBr pellets. NMR spectra were recorded in CDCl~3~ with tetramethylsilane as the internal standard for ^1^H (600, 400 MHz) or ^13^C (150, 100 MHz) NMR. Chemical shifts (δ) are reported in parts per million, and spin--spin coupling constants (*J*) are given in hertz. High-resolution mass spectrometry (HRMS) spectra were recorded using a quad time-of-flight mass spectrometer. Starting materials **4a**--**j** were synthesized as per literature procedures.^[@ref22],[@cit23b]^ Compound **6d** is known, and its spectral data are in agreement with the literature.^[@cit19a],[@cit19b]^

Representative Procedure for the Synthesis of **4a**--**j** {#sec4.2}
-----------------------------------------------------------

### Synthesis of (*Z*)-*N*-(4-Hydroxybut-2-en-1-yl)-4-methyl-*N*-(prop-2-yn-1-yl)benzenesulfonamide (**4a**) {#sec4.2.1}

Benzenesulfonamide (0.9 g, 3.1 mmol) was reacted with (*Z*)-4-bromobut-2-en-1-yl acetate (0.6 g, 3.1 mmol) in the presence of NaH (0.115 g, 4.65 mmol, 55--60% suspension in mineral oil) under a nitrogen atmosphere in dimethylformamide (25 mL) at 0 °C. After the completion of the reaction, the reaction mixture was treated with saturated brine solution and the organic layer was extracted with ethyl acetate (2 × 30 mL) and dried over anhydrous Na~2~SO~4~ to get the crude product of (*Z*)-4-(4-methyl-*N*-(prop-2-yn-1-yl)phenylsulfonamido)but-2-en-1-yl acetate, which was purified by column chromatography using ethyl acetate and hexane as eluents (EtOAc/hexane, 6:4) to give the pure compound in 60% yield. To a stirred solution of (*Z*)-4-(4-methyl-*N*-(prop-2-yn-1-yl)phenylsulfonamido)but-2-en-1-yl acetate (0.8 g, 2.0 mmol) in methanol (20 mL) was added K~2~CO~3~ (0.417 g, 3.0 mmol) at room temperature. The reaction mixture was stirred for 4 h. After the completion of the reaction, methanol was evaporated and washed with saturated brine solution and the organic layer was extracted using ethyl acetate (2 × 30 mL). The crude product was purified by column chromatography using ethyl acetate and hexane as eluents (EtOAc/hexane, 7:3) to give desired alcohol (*Z*)-*N*-(4-hydroxybut-2-en-1-yl)-4-methyl-*N*-(prop-2-yn-1-yl)benzenesulfonamide, **4a**, in 50% yield.

### (*Z*)-*N*-(4-Hydroxybut-2-en-1-yl)-4-methyl-*N*-(prop-2-yn-1-yl)benzenesulfonamide (**4a**) {#sec4.2.2}

Yellow oil; *R*~f~ (hexane/EtOAc 3:2) 0.50; yield 300 mg, 62%; ^1^H NMR (600 MHz, CDCl~3~) δ 2.00 (t, *J* = 2.4 Hz, 1H), 2.34 (s, 3H), 2.56 (br s, 1H), 3.80 (d, *J* = 7.8 Hz, 2H), 4.02 (s, 2H), 4.14 (d, *J* = 6.6 Hz, 2H), 5.35--5.39 (m, 1H), 5.74--5.79 (m, 1H), 7.22 (d, *J* = 8.4 Hz, 2H), 7.63 (d, *J* = 8.4 Hz, 2H); ^13^C NMR (150 MHz, CDCl~3~) δ 21.6, 36.0, 43.1, 57.9, 74.1, 76.6, 125.1, 127.7, 129.6, 134.6, 135.5, 143.9; IR (KBr, neat) 3551, 2922, 2864, 2252, 2119, 1597, 1494, 1330, 1162, 1007, 766 cm^--1^; HRMS (electrospray ionization (ESI)) calcd for C~14~H~18~NO~3~S (M + H)^+^ 280.1002, found 280.1009.

### (*Z*)-*N*-(But-2-yn-1-yl)-*N*-(4-hydroxybut-2-en-1-yl)-4-methylbenzenesulfonamide (**4b**) {#sec4.2.3}

Colorless oil; *R*~f~ (hexane/EtOAc 3:2) 0.50; yield 314 mg, 60%; ^1^H NMR (600 MHz, CDCl~3~) δ 1.55 (t, *J* = 2.2 Hz, 3H), 1.84 (br s, 1H), 2.43 (s, 3H), 3.86 (d, *J* = 7.2 Hz, 2H), 4.01 (d, *J* = 2.4 Hz, 2H), 4.20 (d, *J* = 6.8 Hz, 2H), 5.48--5.52 (m, 1H), 5.84--5.88 (m, 1H), 7.31 (d, *J* = 7.2 Hz, 2H), 7.73 (d, *J* = 7.2 Hz, 2H); ^13^C NMR (150 MHz, CDCl~3~) δ 3.3, 21.6, 36.7, 43.0, 58.0, 71.8, 82.1, 125.8, 128.0, 129.5, 134.2, 135.8, 143.6; IR (KBr, neat) 3537, 2922, 2855, 2223, 1598, 1446, 1342, 1162, 1092, 898, 766 cm^--1^; HRMS (ESI) calcd for C~15~H~20~NO~3~S (M + H)^+^ 294.1158, found 294.1158.

### (*Z*)-*N*-(Hex-2-yn-1-yl)-*N*-(4-hydroxybut-2-en-1-yl)-4-methylbenzenesulfonamide (**4c**) {#sec4.2.4}

Yellow oil; *R*~f~ (hexane/EtOAc 3:2) 0.50; yield 265 mg, 60%; ^1^H NMR (400 MHz, CDCl~3~) δ 0.79 (t, *J* = 7.2 Hz, 3H), 1.23--1.29 (m, 2H), 1.85--1.89 (m, 2H), 2.41 (s, 3H), 2.65 (br s, 1H), 3.86 (d, *J* = 7.2 Hz, 2H), 4.05 (d, *J* = 1.6 Hz, 2H), 4.19 (d, *J* = 6.4 Hz, 2H), 5.43--5.50 (m, 1H), 5.81--5.87 (m, 1H), 7.30 (d, *J* = 8.4 Hz, 2H), 7.71 (d, *J* = 8.4 Hz, 2H); ^13^C NMR (150 MHz, CDCl~3~) δ 13.4, 20.3, 21.4, 21.7, 36.5, 42.9, 57.8, 72.4, 86.3, 125.4, 127.7, 129.4, 134.3, 135.7, 143.5; IR (KBr, neat) 3533, 2930, 2872, 2225, 1598, 1456, 1344, 1161, 1020, 900, 768 cm^--1^; HRMS (ESI) calcd for C~17~H~24~NO~3~S (M + H)^+^ 322.1471, found 322.1471.

### (*Z*)-*N*-(4-Hydroxybut-2-en-1-yl)-4-methyl-*N*-(3-phenylprop-2-yn-1-yl)benzenesulfonamide (**4d**) {#sec4.2.5}

White solid; mp 47--49 °C; *R*~f~ (hexane/EtOAc 3:2) 0.50; yield 134 mg, 50%; ^1^H NMR (400 MHz, CDCl~3~) δ 2.31 (s, 3H), 2.40 (br s, 1H), 3.95 (d, *J* = 7.2 Hz, 2H), 4.21 (d, *J* = 6.8 Hz, 2H), 4.28 (s, 2H), 5.51--5.54 (m, 1H), 5.86--5.87 (m, 1H), 7.07 (dd, *J* = 8.4 and 1.2 Hz, 2H), 7.22--7.25 (m, 5H), 7.75 (d, *J* = 8.4 Hz, 2H); ^13^C NMR (150 MHz, CDCl~3~) δ 21.5, 37.0, 43.3, 58.1, 81.6, 85.9, 122.0, 125.5, 127.9, 128.3, 128.7, 129.7, 131.6, 134.6, 135.6, 143.8; IR (KBr, neat) 3526, 2922, 2870, 1143, 1599, 1491, 1345, 1161, 1022, 896, 761 cm^--1^; HRMS (ESI) calcd for C~20~H~22~NO~3~S (M + H)^+^ 356.1315, found 356.1320.

### (*Z*)-*N*-(4-Hydroxybut-2-en-1-yl)-*N*-(3-(3-methoxyphenyl)prop-2-yn-1-yl)-4-methylbenzene-sulfonamide (**4e**) {#sec4.2.6}

Yellow gum; *R*~f~ (hexane/EtOAc 3:2) 0.50; yield 135 mg, 50%; ^1^H NMR (400 MHz, CDCl~3~) δ 2.33 (s, 3H), 2.75 (s, 3H), 3.93 (d, *J* = 6.8 Hz, 2H), 4.21 (dd, *J* = 5.2 and 2.5 Hz, 2H), 4.27 (s, 2H), 5.49--5.54 (m, 1H), 5.85--5.89 (m, 1H), 6.60 (s, 1H), 6.65 (d, *J* = 7.6 Hz, 1H), 6.81--6.84 (m, 1H), 7.12--7.16 (m, 1H), 7.26 (d, *J* = 8.4 Hz, 2H), 7.75 (dd, *J* = 8.4 and 2.0 Hz, 2H); ^13^C NMR (150 MHz, CDCl~3~) δ 21.5, 36.9, 43.3, 55.3, 58.1, 81.5, 85.8, 114.6, 117.1, 123.0, 124.0, 125.4, 127.9, 129.4, 129.7, 134.6, 135.6, 143.9, 159.2; IR (KBr, neat) 3530, 2922, 2873, 2229, 1578, 1486, 1345, 1160, 1044, 949, 780 cm^--1^; HRMS (ESI) calcd for C~21~H~24~NO~4~S (M + H)^+^ 386.1421, found 386.1419.

### (*Z*)-*N*-(3-(4-Chlorophenyl)prop-2-yn-1-yl)-*N*-(4-hydroxybut-2-en-1-yl)-4-methylbenzene-sulfonamide (**4f**) {#sec4.2.7}

White solid; mp 80--82 °C; *R*~f~ (hexane/EtOAc 3:2) 0.50; yield 270 mg, 60%; ^1^H NMR (400 MHz, CDCl~3~) δ 2.36 (s, 3H), 3.96 (d, *J* = 7.2 Hz, 2H), 4.23 (d, *J* = 6.8 Hz, 2H), 4.30 (s, 2H), 5.55--5.59 (m, 1H), 5.89--5.93 (m, 1H), 7.00 (d, *J* = 8.4 Hz, 2H), 7.22 (d, *J* = 8.4 Hz, 2H), 7.27 (d, *J* = 8.4 Hz, 2H), 7.77 (d, *J* = 8.4 Hz, 2H); ^13^C NMR (150 MHz, CDCl~3~) δ 21.7, 37.0, 43.4, 58.3, 82.9, 84.9, 120.5, 125.9, 128.0, 128.8, 129.8, 132.9, 134.5, 134.9, 135.8, 143.9; IR (KBr, neat) 3528, 2927, 2870, 2249, 1596, 1491, 1341, 1163, 1059, 900, 764 cm^--1^; HRMS (ESI) calcd for C~20~H~21~ClNO~3~S (M + H)^+^ 390.0925, found 390.0925.

### (*Z*)-*N*-(3-(4-Bromophenyl)prop-2-yn-1-yl)-*N*-(4-hydroxybut-2-en-1-yl)-4-methylbenzenesulfonamide (**4g**) {#sec4.2.8}

White solid; mp 98--100 °C; *R*~f~ (hexane/EtOAc 3:2) 0.50; yield 136 mg, 50%; ^1^H NMR (600 MHz, CDCl~3~) δ 2.36 (s, 3H), 3.95 (d, *J* = 7.2 Hz, 2H), 4.23 (d, *J* = 6.6 Hz, 2H), 4.29 (s, 2H), 5.54--5.59 (m, 1H), 5.88--5.92 (m, 1H), 6.93 (d, *J* = 8.4 Hz, 2H), 7.27 (d, *J* = 8.4 Hz, 2H), 7.38 (d, *J* = 8.4 Hz, 2H), 7.76 (d, *J* = 8.4 Hz, 2H); ^13^C NMR (150 MHz, CDCl~3~) δ 21.6, 37.0, 43.4, 58.2, 83.1, 84.9, 121.0, 123.0, 125.7, 128.0, 129.8, 131.6, 133.1, 134.6, 135.7, 143.9; IR (KBr, neat) 3514, 2924, 2856, 2248, 1595, 1486, 1345, 1160, 1012, 897, 767 cm^--1^; HRMS (ESI) calcd for C~20~H~21~BrNO~3~S (M + H)^+^ 436.0420 (Br^81^), found 436.0416.

### (*Z*)-*N*-(3-(4-Fluorophenyl)prop-2-yn-1-yl)-*N*-(4-hydroxybut-2-en-1-yl)-4-methylbenzene-sulfonamide (**4h**) {#sec4.2.9}

White solid; mp 45--47 °C; *R*~f~ (hexane/EtOAc 3:2) 0.50; yield 186 mg, 50%; ^1^H NMR (600 MHz, CDCl~3~) δ 2.36 (s, 3H), 3.96 (d, *J* = 7.2 Hz, 2H), 4.23 (dd, *J* = 6.6 and 1.2 Hz, 2H), 4.29 (s, 2H), 5.55--5.59 (m, 1H), 5.89--5.93 (m, 1H), 6.94 (t, *J* = 8.4 Hz, 2H), 7.06 (d, *J* = 8.4 Hz, 2H), 7.27 (d, *J* = 8.4 Hz, 2H), 7.77 (d, *J* = 8.4 Hz, 2H); ^13^C NMR (150 MHz, CDCl~3~) δ 21.7, 37.1, 43.4, 58.3, 81.6, 85.0, 115.7 (d, *J* = 22.0 Hz), 125.9, 128.0, 128.1, 129.8, 133.7 (d, *J* = 8.6 Hz), 134.5, 135.9, 143.9, 162.8 (d, *J* = 248.9 Hz); IR (KBr, neat) 3534, 2925, 2861, 2250, 1599, 1448, 1345, 1223, 1161, 1093, 895, 733 cm^--1^; HRMS (ESI) calcd for C~20~H~21~FNO~3~S (M + H)^+^ 374.1221, found 374.1221.

### (*Z*)-*N*-(4-Hydroxybut-2-en-1-yl)-*N*-(3-(4-iodophenyl)prop-2-yn-1-yl)-4-methylbenzene-sulfonamide (**4i**) {#sec4.2.10}

White solid; mp 103--105 °C; *R*~f~ (hexane/EtOAc 3:2) 0.50; yield 275 mg, 50%; ^1^H NMR (600 MHz, CDCl~3~) δ 2.36 (s, 3H), 3.94 (d, *J* = 7.2 Hz, 2H), 4.22 (d, *J* = 6.6 Hz, 2H), 4.28 (s, 2H), 5.53--5.59 (m, 1H), 5.87--5.94 (m, 1H), 6.78 (d, *J* = 8.4 Hz, 2H), 7.27 (d, *J* = 8.4 Hz, 2H), 7.58 (d, *J* = 8.4 Hz, 2H), 7.76 (d, *J* = 8.4 Hz, 2H); ^13^C NMR (150 MHz, CDCl~3~) δ 21.7, 37.1, 43.4, 58.3, 83.4, 85.1, 94.8, 121.6, 125.8, 128.1, 129.8, 133.2, 134.6, 135.8, 137.6, 143.9; IR (KBr, neat) 3509, 2922, 2854, 2220, 1597, 1482, 1345, 1160, 1057, 996, 765, 662 cm^--1^; HRMS (ESI) calcd for C~20~H~21~INO~3~S (M + H)^+^ 482.0281, found 482.0289.

### (*Z*)-*N*-(3-(3,5-Dimethylphenyl)prop-2-yn-1-yl)-*N*-(4-hydroxybut-2-en-1-yl)-4-methylbenzenesulfonamide (**4j**) {#sec4.2.11}

White oil; *R*~f~ (hexane/EtOAc 3:2) 0.50; yield 121 mg, 45%; ^1^H NMR (600 MHz, CDCl~3~) δ 2.25 (s, 6H), 2.37 (s, 3H), 3.94 (d, *J* = 7.2 Hz, 2H), 4.23 (br s, 2H), 4.30 (s, 2H), 5.55--5.59 (m, 1H), 5.88--5.92 (m, 1H), 6.68 (s, 2H), 6.92 (s, 1H), 7.28 (d, *J* = 8.4 Hz, 2H), 7.77 (d, *J* = 8.4 Hz, 2H); ^13^C NMR (150 MHz, CDCl~3~) δ 21.3, 21.7, 37.1, 43.3, 58.3, 81.0, 86.4, 121.7, 125.9, 128.1, 129.4, 129.8, 130.7, 134.5, 135.9, 138.0, 143.8; IR (KBr, neat) 3442, 2922, 2854, 2220, 1598, 1456, 1346, 1161, 1020, 900, 766 cm^--1^; HRMS (ESI) calcd for C~22~H~26~NO~3~S (M + H)^+^ 384.1628, found 384.1635.

Representative Procedure for the Synthesis of Vinylpyrrolidines (**5a--j**) {#sec4.3}
---------------------------------------------------------------------------

### Synthesis of (*Z*)-3-(Chloromethylene)-1-tosyl-4-vinylpyrrolidine (**5a**) {#sec4.3.1}

To a stirred solution of N-tethered alkyne-alkenol **4a** (100 mg, 0.28 mmol) in dry 1,2-dichloroethane (4 mL) was added indium trichloride (68 mg, 0.308 mmol) at 80 °C (N~2~ atmosphere). The reaction mixture was refluxed for 12 h. After the completion of the reaction, dichloroethane was evaporated and washed with brine solution and the organic layer was extracted with ethyl acetate (2 × 15 mL) and dried over anhydrous Na~2~SO~4~. Evaporation of the solvent gave the crude product, which was purified by column chromatography using ethyl acetate and hexane (EtOAc/hexane, 2:8) as eluents.

### (*Z*)-3-(Chloromethylene)-1-tosyl-4-vinylpyrrolidine (**5a**, E/Z Mixture, E:Z::13:87, Only Z-Isomer Is Considered) {#sec4.3.2}

Yellow oil; *R*~f~ (hexane/EtOAc 9:1) 0.50; yield 50 mg, 47%; ^1^H NMR (400 MHz, CDCl~3~) δ 2.44 (s, 3H), 2.79 (dd, *J* = 12.0 and 7.2 Hz, 1H), 3.08--3.10 (m, 1H), 3.41 (dd, *J* = 12.0 and 5.2 Hz, 1H), 3.56 (d, *J* = 15.6 Hz, 1H), 3.77 (d, *J* = 16.0 Hz, 1H), 5.12 (s, 1H), 5.15 (d, *J* = 4.0 Hz, 1H), 5.65--5.71 (m, 1H), 5.78--5.79 (m, 1H), 7.34 (d, *J* = 8.0 Hz, 2H), 7.67 (d, *J* = 8.0 Hz, 2H); ^13^C NMR (100 MHz, CDCl~3~) δ 21.8, 40.7, 47.2, 49.2, 117.5, 125.8, 127.3, 127.8, 130.1, 133.4, 136.4, 144.2; IR (KBr, neat) 2923, 2853, 2226, 1597, 1457, 1347, 1166, 1056, 815, 752, 570 cm^--1^; HRMS (ESI) calcd for C~14~H~17~ClNO~2~S (M + H)^+^ 298.0663, found 298.0664.

### 3-(1-Chloroethylidene)-1-tosyl-4-vinylpyrrolidine (**5b**, E/Z Mixture, E:Z::30:70) {#sec4.3.3}

Yellow oil; *R*~f~ (hexane/EtOAc 9:1) 0.50; yield 74 mg, 70%; ^1^H NMR (600 MHz, CDCl~3~) δ 1.90 (s, 3H), 2.36 (s, 3H), 3.07 (dd, *J* = 9.4 and 6.0 Hz, 1H, minor), 3.17 (dd, *J* = 9.0 and 6.6 Hz, 1H, major), 3.22--3.28 (m, 2H, major), 3.32--3.41 (m, 2H, minor), 3.56 (d, *J* = 14.0 Hz, 1H, minor), 3.65 (d, *J* = 15.6 Hz, 1H, major), 3.88--3.91 (m, 1H), 4.96--5.03 (m, 2H), 5.57--5.63 (m, 1H), 7.27 (d, *J* = 7.8 Hz, 2H), 7.63 (d, *J* = 7.8 Hz, 2H); ^13^C NMR (150 MHz, CDCl~3~) δ 21.7, 22.5, 23.4, 45.8, 46.4, 50.4, 52.1, 53.3, 54.7, 116.0, 116.3, 125.1, 127.2, 128.0, 128.1, 129.9, 133.3, 135.3, 136.2, 144.0; IR (KBr, neat) 2923, 2854, 1598, 1450, 1348, 1164, 1093, 815, 754, 665 cm^--1^; HRMS (ESI) calcd for C~15~H~19~ClNO~2~S (M + H)^+^ 312.0820, found 312.0821.

### (*E*)-3-(1-Chloroethylidene)-1-tosyl-4-vinylpyrrolidine (*E*-**5b**)^[@cit17d]^ {#sec4.3.4}

Yellow oil; *R*~f~ (hexane/EtOAc 95:5, TLC was run two times) 0.55; ^1^H NMR (600 MHz, CDCl~3~) δ 1.99 (d, *J* = 1.2 Hz, 3H), 2.45 (s, 3H), 3.16 (dd, *J* = 9.5 and 6.7 Hz, 1H), 3.40 (dd, *J* = 9.5 and 1.9 Hz, 1H), 3.48 (t, *J* = 6.9 Hz, 1H), 3.65 (d, *J* = 14.0 Hz, 1H), 3.96 (dt, *J* = 14.0 and 1.4 Hz, 1H), 5.05--5.11 (m, 2H), 5.66--5.72 (m, 1H), 7.35 (d, *J* = 8.0 Hz, 2H), 7.71 (d, *J* = 8.0 Hz, 2H); ^13^C NMR (150 MHz, CDCl~3~) δ 21.8, 23.5, 46.5, 50.4, 53.4, 116.2, 124.5, 128.1, 130.0, 132.5, 133.1, 135.3, 144.2.

### (*Z*)-3-(1-Chloroethylidene)-1-tosyl-4-vinylpyrrolidine (*Z*-**5b**) {#sec4.3.5}

Yellow oil; *R*~f~ (hexane/EtOAc 95:5, TLC was run two times) 0.50; ^1^H NMR (600 MHz, CDCl~3~) δ 1.98 (d, *J* = 0.5 Hz, 3H), 2.44 (s, 3H), 3.25 (dd, *J* = 9.0 and 6.5 Hz, 1H), 3.31--3.35 (m, 2H), 3.73 (dd, *J* = 15.0 and 2.0 Hz, 1H), 3.98 (dt, *J* = 15.0 and 1.8 Hz, 1H), 5.03--5.07 (m, 2H), 5.66--5.72 (m, 1H), 7.35 (d, *J* = 8.0 Hz, 2H), 7.71 (d, *J* = 8.0 Hz, 2H); ^13^C NMR (150 MHz, CDCl~3~) δ 21.8, 22.6, 46.0, 52.2, 54.7, 116.4, 125.2, 128.2, 130.0, 132.3, 133.3, 136.2, 144.1.

### 3-(1-Chlorobutylidene)-1-tosyl-4-vinylpyrrolidine (**5c**, E/Z Mixture, E:Z::40:60) {#sec4.3.6}

Yellow oil; *R*~f~ (hexane/EtOAc 9:1) 0.50; yield 81 mg, 77%; ^1^H NMR (400 MHz, CDCl~3~) δ 0.82 (t, *J* = 7.2 Hz, 3H, major), 0.85 (t, *J* = 7.2 Hz, 3H, minor), 1.46--1.57 (m, 2H), 2.15--2.22 (m, 2H), 2.44 (s, 3H), 3.14 (dd, *J* = 9.6 and 6.4 Hz, 1H, minor), 3.24 (dd, *J* = 9.6 and 7.2 Hz, 1H, major), 3.30--3.33 (m, 1H), 3.39 (dd, *J* = 9.6 and 2.0 Hz, 1H, major), 3.49 (t, *J* = 6.8 Hz, 1H, minor), 3.65 (d, *J* = 13.6 Hz, 1H, minor), 3.74 (d, *J* = 14.8 Hz, 1H, major), 3.94--3.96 (m, 1H, major), 3.98--4.00 (m, 1H, minor), 5.04--5.12 (m, 2H), 5.64--5.75 (m, 1H), 7.34 (d, *J* = 8.0 Hz, 2H), 7.69 (d, *J* = 8.0 Hz, 2H, major), 7.70 (d, *J* = 8.0 Hz, 2H, minor); ^13^C NMR (150 MHz, CDCl~3~) δ 13.3, 13.5, 20.5, 20.7, 21.8, 37.2, 38.5, 45.8, 46.4, 50.2, 52.2, 53.2, 54.7, 116.0, 116.3, 128.1, 128.2, 129.5, 129.9, 130.4, 132.4, 132.5, 133.4, 135.4, 136.9, 144.0, 144.1; IR (KBr, neat) 2962, 2871, 1637, 1457, 1349, 1164, 1093, 815, 708, 665 cm^--1^; HRMS (ESI) calcd for C~17~H~23~ClNO~2~S (M + H)^+^ 340.1133, found 340.1136.

### (*E*)-3-(1-Chlorobutylidene)-1-tosyl-4-vinylpyrrolidine (*E*-**5c**) {#sec4.3.7}

Yellow oil; *R*~f~ (hexane/EtOAc 95:5, TLC was run two times) 0.55; ^1^H NMR (600 MHz, CDCl~3~) δ 0.86 (t, *J* = 7.2 Hz, 3H), 1.54 (dd, *J* = 14.6 and 7.2 Hz, 2H), 2.17 (t, *J* = 7.2 Hz, 2H), 2.44 (s, 3H), 3.15 (dd, *J* = 9.4 and 6.7 Hz, 1H), 3.40 (dd, *J* = 9.4 and 1.6 Hz, 1H), 3.49 (t, *J* = 6.7 Hz, 1H), 3.67 (d, *J* = 13.7 Hz, 1H), 3.98 (d, *J* = 13.7 Hz, 1H), 5.04--5.11 (m, 2H), 5.66--5.72 (m, 1H), 7.34 (d, *J* = 8.0 Hz, 2H), 7.70 (d, *J* = 8.0 Hz, 2H); ^13^C NMR (150 MHz, CDCl~3~) δ 13.3, 20.5, 21.8, 38.6, 46.5, 50.3, 53.3, 116.1, 128.1, 129.5, 130.0, 132.5, 133.2, 135.4, 144.2.

### (*Z*)-3-(1-Chlorobutylidene)-1-tosyl-4-vinylpyrrolidine (*Z*-**5c**) {#sec4.3.8}

Yellow oil; *R*~f~ (hexane/EtOAc 95:5, TLC was run two times) 0.50; ^1^H NMR (600 MHz, CDCl~3~) δ 0.84 (t, *J* = 7.4 Hz, 3H), 1.46--1.53 (m, 2H), 2.22 (dd, *J* = 13.7 and 7.0 Hz, 2H), 2.44 (s, 3H), 3.27 (dd, *J* = 9.6 and 6.4 Hz, 1H), 3.31--3.35 (m, 2H), 3.76 (d, *J* = 15.0 Hz, 1H), 3.98 (dd, *J* = 15.0 and 1.3 Hz, 1H), 5.05--5.08 (m, 2H), 5.67--5.73 (m, 1H), 7.35 (d, *J* = 8.0 Hz, 2H), 7.72 (d, *J* = 8.0 Hz, 2H); ^13^C NMR (150 MHz, CDCl~3~) δ 13.5, 20.7, 21.8, 37.2, 45.9, 52.2, 54.8, 116.3, 128.2, 130.0, 130.4, 132.4, 133.4, 137.0, 144.1.

### (*Z*)-3-(Chloro(phenyl)methylene)-1-tosyl-4-vinylpyrrolidine (**5d**, E/Z Mixture, E:Z::16:84, Only Z-Isomer Is Considered) {#sec4.3.9}

Brown oil; *R*~f~ (hexane/EtOAc 9:1) 0.50; yield 78 mg, 75%; ^1^H NMR (600 MHz, CDCl~3~) δ 2.46 (s, 3H), 3.28 (dd, *J* = 9.6 and 6.6 Hz, 1H), 3.32 (dd, *J* = 9.6 and 3.0 Hz, 1H), 3.36--3.40 (m, 1H), 4.02 (d, *J* = 15.6 Hz, 1H), 4.13 (d, *J* = 7.2 Hz, 1H), 4.78 (d, *J* = 17.4 Hz, 1H), 4.89 (d, *J* = 10.2 Hz, 1H), 5.52--5.61 (m, 1H), 7.27--7.30 (m, 5H), 7.37 (d, *J* = 8.4 Hz, 2H), 7.75 (d, *J* = 7.8 Hz, 2H); ^13^C NMR (150 MHz, CDCl~3~) δ 21.8, 46.3, 52.8, 54.8, 116.8, 127.0, 128.2, 128.4, 128.5, 128.7, 129.0, 130.0, 132.8, 136.2, 136.3, 137.2, 144.1; IR (KBr, neat) 2978, 2849, 1634, 1483, 1347, 1161, 1064, 898, 748, 668 cm^--1^; HRMS (ESI) calcd for C~20~H~21~ClNO~2~S (M + H)^+^ 374.0976, found 374.0984.

### (*Z*)-3-(Chloro(3-methoxyphenyl)methylene)-1-tosyl-4-vinylpyrrolidine (**5e**, E/Z Mixture, E:Z::6:94, Only Z-Isomer Is Considered) {#sec4.3.10}

Colorless oil; *R*~f~ (hexane/EtOAc 9:1) 0.50; yield 68 mg, 65%; ^1^H NMR (400 MHz, CDCl~3~) δ 2.46 (s, 3H), 3.26 (dd, *J* = 9.2 and 6.4 Hz, 1H), 3.34 (dd, *J* = 11.6 and 2.4 Hz, 1H), 3.36--3.43 (m, 1H), 3.77 (s, 3H), 4.00 (d, *J* = 15.6 Hz, 1H), 4.12 (d, *J* = 15.6 Hz, 1H), 4.83 (d, *J* = 17.2 Hz, 1H), 4.93 (d, *J* = 9.6 Hz, 1H), 5.55--5.64 (m, 1H), 6.83 (d, *J* = 8.0 Hz, 2H), 6.89 (d, *J* = 8.0 Hz, 1H), 7.21 (t, *J* = 8.0 Hz, 1H), 7.37 (d, *J* = 8.0 Hz, 2H), 7.75 (d, *J* = 8.0 Hz, 2H); ^13^C NMR (100 MHz, CDCl~3~) δ 21.8, 46.3, 52.7, 54.8, 55.5, 114.1, 114.7, 116.9, 120.9, 126.8, 128.2, 129.4, 130.0, 132.8, 136.2, 136.4, 138.4, 144.1, 159.4; IR (KBr, neat) 2956, 2852, 1638, 1451, 1348, 1162, 1046, 815, 754, 669 cm^--1^; HRMS (ESI) calcd for C~21~H~23~ClNO~3~S (M + H)^+^ 404.1082, found 404.1082.

### (*Z*)-3-(Chloro(4-chlorophenyl)methylene)-1-tosyl-4-vinylpyrrolidine (**5f**, E/Z Mixture, E:Z::14:86, Only Z-Isomer Is Considered) {#sec4.3.11}

Yellow gum; *R*~f~ (hexane/EtOAc 9:1) 0.50; yield 70 mg, 67%; ^1^H NMR (600 MHz, CDCl~3~) δ 2.46 (s, 3H), 3.28--3.31 (m, 2H), 3.34--3.38 (m, 1H), 4.00 (d, *J* = 15.6 Hz, 1H), 4.10 (d, *J* = 15.6 Hz, 1H), 4.80 (dt, *J* = 17.2 and 1.2 Hz, 1H), 4.92 (dd, *J* = 10.8 and 1.2 Hz, 1H), 5.51--5.60 (m, 1H), 7.23--7.27 (m, 4H), 7.37 (d, *J* = 8.0 Hz, 2H), 7.74 (d, *J* = 8.0 Hz, 2H); ^13^C NMR (150 MHz, CDCl~3~) δ 21.8, 46.4, 52.8, 54.8, 117.1, 125.8, 128.2, 128.6, 129.0, 129.98, 130.0, 135.0, 135.6, 136.2, 137.0, 144.2; IR (KBr, neat) 2926, 2853, 1640, 1595, 1490, 1350, 1162, 1092, 830, 776, 665 cm^--1^; HRMS (ESI) calcd for C~20~H~20~Cl~2~NO~2~S (M + H)^+^ 408.0586, found 408.0585.

### (*Z*)-3-((4-Bromophenyl)chloromethylene)-1-tosyl-4-vinylpyrrolidine (**5g**, E/Z Mixture, E:Z::15:85, Only Z-Isomer Is Considered) {#sec4.3.12}

Brown gum; *R*~f~ (hexane/EtOAc 9:1) 0.50; yield 80 mg, 77%; ^1^H NMR (600 MHz, CDCl~3~) δ 2.39 (s, 3H), 3.19--3.23 (m, 2H), 3.25--3.30 (m, 1H), 3.92 (d, *J* = 15.6 Hz, 1H), 4.03 (d, *J* = 15.6 Hz, 1H), 4.73 (d, *J* = 17.4 Hz, 1H), 4.85 (d, *J* = 10.2 Hz, 1H), 5.45--5.51 (m, 1H), 7.11 (d, *J* = 8.4 Hz, 2H), 7.30 (d, *J* = 8.4 Hz, 2H), 7.35 (d, *J* = 8.4 Hz, 2H), 7.67 (d, *J* = 8.4 Hz, 2H); ^13^C NMR (150 MHz, CDCl~3~) δ 21.8, 46.4, 52.9, 54.8, 117.2, 123.2, 128.2, 130.0, 130.2, 131.6, 131.9, 132.6, 136.0, 136.1, 137.0, 144.2; IR (KBr, neat) 2924, 2852, 1639, 1486, 1349, 1162, 1094, 816, 732, 665 cm^--1^; HRMS (ESI) calcd for C~20~H~20~BrClNO~2~S (M + H)^+^ 454.0061 (Br^81^), found 454.0044.

### (*Z*)-3-(Chloro(4-fluorophenyl)methylene)-1-tosyl-4-vinylpyrrolidine (**5h**, E/Z Mixture, E:Z::14:86, Only Z-Isomer Is Considered) {#sec4.3.13}

Brown oil; *R*~f~ (hexane/EtOAc 9:1) 0.50; yield 94 mg, 90%; ^1^H NMR (600 MHz, CDCl~3~) δ 2.46 (s, 3H), 3.95 (d, *J* = 4.8 Hz, 2H), 3.36 (d, *J* = 6.6 Hz, 1H), 4.00 (d, *J* = 15.6 Hz, 1H), 4.10 (dd, *J* = 15.6 and 1.8 Hz, 1H), 4.78 (d, *J* = 16.8 Hz, 1H), 4.90 (d, *J* = 10.2 Hz, 1H), 5.51--5.57 (m, 1H), 6.98 (t, *J* = 8.4 Hz, 2H), 7.29 (d, *J* = 8.4 Hz, 2H), 7.37 (d, *J* = 8.4 Hz, 2H), 7.76 (d, *J* = 8.4 Hz, 2H); ^13^C NMR (150 MHz, CDCl~3~) δ 21.8, 46.4, 52.8, 54.8, 115.4 (d, *J* = 21.6 Hz), 117.0, 126.0, 128.0, 128.2, 129.9, 130.5 (d, *J* = 8.4 Hz), 132.6, 136.2, 136.6, 144.2, 162.8 (d, *J* = 247.8 Hz); IR (KBr, neat) 2926, 2854, 1599, 1507, 1353, 1161, 1095, 839, 777, 666 cm^--1^; HRMS (ESI) calcd for C~20~H~20~ClFNO~2~S (M + H)^+^ 392.0882, found 392.0882.

### (*Z*)-3-(Chloro(4-iodophenyl)methylene)-1-tosyl-4-vinylpyrrolidine (**5i**, E/Z Mixture, E:Z::14:96, Only Z-Isomer Is Considered) {#sec4.3.14}

Deep brown gum; *R*~f~ (hexane/EtOAc 9:1) 0.50; yield 46 mg, 45%; ^1^H NMR (600 MHz, CDCl~3~) δ 2.46 (s, 3H), 3.26--3.32 (m, 2H), 3.33--3.36 (m, 1H), 3.98 (d, *J* = 15.6 Hz, 1H), 4.09 (d, *J* = 15.6 Hz, 1H), 4.82 (d, *J* = 17.4 Hz, 1H), 4.93 (d, *J* = 10.2 Hz, 1H), 5.53--5.59 (m, 1H), 7.05 (d, *J* = 8.4 Hz, 2H), 7.37 (d, *J* = 7.8 Hz, 2H), 7.63 (d, *J* = 8.4 Hz, 2H), 7.74 (d, *J* = 7.7 Hz, 2H); ^13^C NMR (150 MHz, CDCl~3~) δ 21.8, 46.4, 52.9, 54.8, 95.0, 117.2, 125.9, 128.2, 129.8, 130.0, 130.1, 130.3, 132.6, 136.2, 136.6, 137.0, 137.6, 137.9, 144.2; IR (KBr, neat) 2923, 2853, 1597, 1480, 1348, 1161, 1093, 897, 816, 665 cm^--1^; HRMS (ESI) calcd for C~20~H~20~ClINO~2~S (M + H)^+^ 499.9942, found 499.9942.

### (*Z*)-3-(Chloro(3,5-dimethylphenyl)methylene)-1-tosyl-4-vinylpyrrolidine (**5j**, E/Z Mixture, E:Z::40:60) {#sec4.3.15}

Yellow oil; *R*~f~ (hexane/EtOAc 9:1) 0.50; yield 26 mg, 25%; ^1^H NMR (600 MHz, CDCl~3~) δ 2.26 (s, 6H, major), 2.32 (s, 6H, minor), 2.44 (s, 3H, minor), 2.46 (s, 3H, major), 3.22--3.28 (m, 3H, minor), 3.32--3.39 (m, 3H, major), 3.63--3.65 (m, 1H, minor), 3.70 (d, *J* = 14.4 Hz, 1H, major), 4.00 (d, *J* = 15.6 Hz, 1H, major), 4.03 (dd, *J* = 14.4 and 2.4 Hz, 1H, minor), 4.10 (dd, *J* = 15.6 and 1.8 Hz, 1H), 4.81 (d, *J* = 16.8 Hz, 1H, major), 4.92 (d, *J* = 10.2 Hz, 1H, major), 5.11 (d, *J* = 10.2 Hz, 1H, minor), 5.18 (d, *J* = 16.8 Hz, 1H, minor), 5.56--5.60 (m, 1H, major), 5.71--5.77 (m, 1H, minor), 6.87 (s, 1H), 6.91 (s, 2H), 7.29 (d, *J* = 8.4 Hz, 2H, minor), 7.37 (d, *J* = 8.4 Hz, 2H), 7.63 (d, *J* = 8.4 Hz, 2H, minor), 7.77 (d, *J* = 8.4 Hz, 2H, major); ^13^C NMR (150 MHz, CDCl~3~) δ 21.4, 21.5, 21.8, 46.4, 47.2, 51.2, 52.7, 52.9, 54.8, 116.6, 116.7, 125.9, 126.3, 128.0, 128.2, 129.9, 130.0, 130.7, 135.1, 136.7, 137.9, 138.4, 144.0, 144.1; IR (KBr, neat) 2921, 2852, 1636, 1445, 1348, 1162, 1092, 814, 702, 664 cm^--1^; HRMS (ESI) calcd for C~22~H~25~ClNO~2~S (M + H)^+^ 402.1289, found 402.1294.
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